The U.S. Food and Drug Administration (FDA) has accepted a new drug application for iberdomide combined with Darzalex ...
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Iberdomide in Relapsed or ...
Explains why Zero Trust must start at the session layer, via NHP, to hide endpoints and reduce AI-driven attack surfaces.
A strategic approach is needed to address scraping risks and safeguard intellectual capital from automated data harvesting.
Palo Alto Networks’ acquisition of Koi Security signals a strategic shift toward governing AI agents and extensions at the endpoint layer, as enterprises confront a new shadow infrastructure of ...
The NDA is supported by data from the EXCALIBER-RRMM trial, which evaluated the safety and efficacy of iberdomide, an investigational cereblon E3 ligase modulator.
Earlier this month, the now viral social network Moltbook exposed 1.5 million API authentication tokens and 35,000 email addresses within days of launch. The cause: a single misconfigured database ...
Most API vulnerabilities are fast, remote, and easy to exploit. Attackers take full advantage of these attributes.
Drug sponsors should nevertheless bolster their application with “confirmative evidence,” chief regulators Marty Makary and Vinay Prasad said on Wednesday, including mechanistic data or findings from ...
SUSE, a global leader in enterprise open source solutions, today announced it has acquired Losant, an Industrial Internet of ...
Self-hosted agents execute code with durable credentials and process untrusted input. This creates dual supply chain risk, ...
Regulatory uncertainty is no longer background noise. It is a material investment risk that reshapes how capital is deployed and pipelines are prioritized.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results